Latest news

Invizyne Technologies Announces Closing of Initial Public Offering

Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing

Invizyne Technologies Begins Trading on NASDAQ

Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024

Invizyne Technologies Announces Pricing of $15 Million Initial Public Offering

With NREL's Help, GCxN Company Readies for Initial Public Offering

NREL

NREL (DoE) working with Invizyne in their 'Advancing Clean Tech to Energize the Future' project - a fireside chat

Commercializing Invizyne’s cell-free platform - fireside chat with Zachary Karl, PhD, VP of BizDev - and - Lou Basenese

Invizyne IPO: interview with Dr. James J. Lalonde by MDB Capital President and Chief Market Strategist Lou Basenese

MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies